Rigel Pharmaceuticals Statistics
NASDAQ: RIGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
40.09-1.10 (-2.67%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Rigel Pharmaceuticals by the numbers
Rigel Pharmaceuticals has a market capitalization of $754.9 million based on 18.83M shares outstanding. Its trailing P/E ratio is 2.5, and its forward P/E is 8.4. The stock trades 14.5% below its 50-day average and 6.2% above its 200-day average.
Average daily trading volume is 248.06K shares, or about $9.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RIGL valuation vs. peer median
| Metric | RIGL | Peer median | Difference |
|---|---|---|---|
| Market cap | $754.89M | $766.56M | -2% |
| Forward P/E | 8.4 | 3.5 | +140% |
| Avg. volume | 248.06K | 2.28M | -89% |
Peer median across 8 companies: ARDX, IVA, ORIC, COLL, OBX, IRWD, SNDX, VSTM.
Valuation
- Market cap
- $754.89M
- P/E (TTM)
- 2.49
- Forward P/E
- 8.39
- Price / sales (latest FY)
- 2.57
- EPS (TTM)
- $16.07
- Shares outstanding
- 18.83M
Price and trading
- Previous close
- 41.19
- Open
- 40.65
- Day range
- 39.62 – 41.66
- 52-week range
- 24.95 – 52.61
- 52-week change
- -13.26%
- Beta
- —
- Volume
- 352.03K
- Average volume
- 248.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 754.89M
- Pe
- 2.49
- Forward Pe
- 8.39
- Eps
- 16.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 52.61
- Week52 Low
- 24.95
- Avg Volume
- 248.06K
- Shares Outstanding
- 18.83M
- Ma50
- 46.90
- Ma200
- 37.76
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -23.80%
- Pct From52w Low
- 60.68%